Prevention of intraoperative bleeding from neovascularization of the disc in complicated cases of proliferative diabetic retinopathy

O.V. Kashtan, I. A. Levashov, A. A. Petukhova
{"title":"Prevention of intraoperative bleeding from neovascularization of the disc in complicated cases of proliferative diabetic retinopathy","authors":"O.V. Kashtan, I. A. Levashov, A. A. Petukhova","doi":"10.25276/2312-4911-2023-2-98-102","DOIUrl":null,"url":null,"abstract":"Proliferative diabetic retinopathy (PDR) is a major cause of vision loss in diabetic patients and is characterized by neovascularization particularly in optic nerve head (NVD). NVD may bleed spontaneously or be caused by minimal trauma. During vitrectomy, it is often difficult to stop this type of bleeding, thus surgeons are faced with such a problem as poor visualization and residual hemorrhage in the early postoperative period. Aim was to evaluate the clinical efficacy of the platelet-rich plasma (PRP) use in intraoperative bleeding from the NVD during the surgical treatment of PDR. Material and Methods. The group consists of 12 patients (12 eyes). Preoperative examination of all patients revealed the vitreous hemorrhage as well as the retinal traction detachment according to B-scan. A standard three-port vitrectomy (25 g) was performed, accompanied with the removal of proliferated blood vessels, diathermic coagulation, endolaser coagulation of the retina and an intravitreal injection of PRP on the NVD (PRP obtained by one-step closed centrifugation). Vitreal cavity was tamponaded with air. Results. We achieved an almost complete cessation of bleeding into vitreal cavity from NVD in all participants by using the intravitreal injection of the PRP. Conclusion. Intravitreal injection of PRP on the optic disc during vitrectomy is effective and safe. Keywords: proliferative diabetic retinopathy, PDR , neovascularization of the disc, vitreous hemorrhage, platelet-rich plasma, PRP, vitrectomy","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern technologies in ophtalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25276/2312-4911-2023-2-98-102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Proliferative diabetic retinopathy (PDR) is a major cause of vision loss in diabetic patients and is characterized by neovascularization particularly in optic nerve head (NVD). NVD may bleed spontaneously or be caused by minimal trauma. During vitrectomy, it is often difficult to stop this type of bleeding, thus surgeons are faced with such a problem as poor visualization and residual hemorrhage in the early postoperative period. Aim was to evaluate the clinical efficacy of the platelet-rich plasma (PRP) use in intraoperative bleeding from the NVD during the surgical treatment of PDR. Material and Methods. The group consists of 12 patients (12 eyes). Preoperative examination of all patients revealed the vitreous hemorrhage as well as the retinal traction detachment according to B-scan. A standard three-port vitrectomy (25 g) was performed, accompanied with the removal of proliferated blood vessels, diathermic coagulation, endolaser coagulation of the retina and an intravitreal injection of PRP on the NVD (PRP obtained by one-step closed centrifugation). Vitreal cavity was tamponaded with air. Results. We achieved an almost complete cessation of bleeding into vitreal cavity from NVD in all participants by using the intravitreal injection of the PRP. Conclusion. Intravitreal injection of PRP on the optic disc during vitrectomy is effective and safe. Keywords: proliferative diabetic retinopathy, PDR , neovascularization of the disc, vitreous hemorrhage, platelet-rich plasma, PRP, vitrectomy
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
并发增殖性糖尿病视网膜病变术中椎间盘新生血管出血的预防
增殖性糖尿病视网膜病变(PDR)是糖尿病患者视力丧失的主要原因,其特征是视神经头(NVD)的新生血管。NVD可能会自发出血或由最小的创伤引起。在玻璃体切除术中,此类出血往往难以止血,因此外科医生在术后早期面临着视觉不良和残余出血的问题。目的是评价富血小板血浆(PRP)在PDR手术治疗中治疗NVD术中出血的临床疗效。材料和方法。本组共12例患者(12只眼)。术前检查均发现玻璃体出血及视网膜牵引力脱离。进行标准的三孔玻璃体切除术(25g),同时切除增殖血管,透热凝血,视网膜内激光凝血,并在NVD上玻璃体内注射PRP (PRP通过一步封闭离心获得)。玻璃体腔被空气填塞。结果。通过玻璃体内注射PRP,我们几乎完全停止了所有参与者NVD的玻璃体腔出血。结论。玻璃体切除术时视盘玻璃体内注射PRP是安全有效的。关键词:增殖性糖尿病视网膜病变,PDR,椎间盘新生血管,玻璃体出血,富血小板血浆,PRP,玻璃体切除术
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Study of the effectiveness of the treatment of endothelial vascular dysfunction in various stages of primary open-angle glaucoma Diagnostic errors in penetrating wounds of the orbit in children Modern approaches to the diagnosis and treatment of demodicosis Alcohol is undisputed evil, but the patient is lucky Dacryocystorhinostomywith transcutaneous access is not a reason for a cosmetological treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1